BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang H, Liu X, Tan C, Zhou W, Jiang J, Peng W, Zhou X, Mo L, Chen L. Bacterial, viral, and fungal infection-related risk of Parkinson's disease: Meta-analysis of cohort and case-control studies. Brain Behav. 2020;10:e01549. [PMID: 32017453 DOI: 10.1002/brb3.1549] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Howard FHN, Kwan A, Winder N, Mughal A, Collado-Rojas C, Muthana M. Understanding Immune Responses to Viruses-Do Underlying Th1/Th2 Cell Biases Predict Outcome? Viruses 2022;14:1493. [PMID: 35891472 DOI: 10.3390/v14071493] [Reference Citation Analysis]
2 Santos MLC, de Brito BB, da Silva FAF, Sampaio MM, Marques HS, Oliveira e Silva N, de Magalhães Queiroz DM, de Melo FF. Helicobacter pylori infection: Beyond gastric manifestations. World J Gastroenterol 2020; 26(28): 4076-4093 [PMID: 32821071 DOI: 10.3748/wjg.v26.i28.4076] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
3 Nikitina AJ, Chimagomedova AS, Levin OS. [Neurological complications of COVID-19 in elderly people]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:5-15. [PMID: 34870908 DOI: 10.17116/jnevro20211211025] [Reference Citation Analysis]
4 Bindas AJ, Kulkarni S, Koppes RA, Koppes AN. Parkinson's disease and the gut: Models of an emerging relationship. Acta Biomater 2021;132:325-44. [PMID: 33857691 DOI: 10.1016/j.actbio.2021.03.071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
5 Dowd E, McKernan DP. Back to the future: lessons from past viral infections and the link with Parkinson's disease. Neuronal Signal 2021;5:NS20200051. [PMID: 33953960 DOI: 10.1042/NS20200051] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang C, Zheng C. Using Caenorhabditis elegans to Model Therapeutic Interventions of Neurodegenerative Diseases Targeting Microbe-Host Interactions. Front Pharmacol 2022;13:875349. [DOI: 10.3389/fphar.2022.875349] [Reference Citation Analysis]
7 Liu J, Xu F, Nie Z, Shao L. Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease. Front Cell Infect Microbiol 2020;10:570658. [PMID: 33194809 DOI: 10.3389/fcimb.2020.570658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Lotz SK, Blackhurst BM, Reagin KL, Funk KE. Microbial Infections Are a Risk Factor for Neurodegenerative Diseases. Front Cell Neurosci 2021;15:691136. [PMID: 34305533 DOI: 10.3389/fncel.2021.691136] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Cocoros NM, Svensson E, Szépligeti SK, Vestergaard SV, Szentkúti P, Thomsen RW, Borghammer P, Sørensen HT, Henderson VW. Long-term Risk of Parkinson Disease Following Influenza and Other Infections. JAMA Neurol 2021. [PMID: 34694344 DOI: 10.1001/jamaneurol.2021.3895] [Reference Citation Analysis]
10 Guo T, Chen L. Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights. Eur J Inflamm 2022;20:1721727X2210837. [DOI: 10.1177/1721727x221083763] [Reference Citation Analysis]
11 Wang H, Liu X, Tan C, Zhou W, Jiang J, Peng W, Zhou X, Mo L, Chen L. Bacterial, viral, and fungal infection-related risk of Parkinson's disease: Meta-analysis of cohort and case-control studies. Brain Behav. 2020;10:e01549. [PMID: 32017453 DOI: 10.1002/brb3.1549] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
12 Tran VTA, Lee LP, Cho H. Neuroinflammation in neurodegeneration via microbial infections. Front Immunol 2022;13:907804. [DOI: 10.3389/fimmu.2022.907804] [Reference Citation Analysis]
13 Ivanova GE, Bogolepova AN, Levin OS, Shamalov NA, Khasanova DR, Yanishevsky SN, Zakharov VV, Khatkova SE, Stakhovskya LV. [Current issues of treatment and rehabilitation of patients with neurological disorders and the consequences of COVID-19. Resolution of Advisory Board]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:145-51. [PMID: 34283545 DOI: 10.17116/jnevro2021121061145] [Reference Citation Analysis]
14 Fernández-Espejo E. Microorganisms that are related with increased risk for Parkinson's disease. Neurologia (Engl Ed) 2020:S0213-4853(20)30301-7. [PMID: 33160724 DOI: 10.1016/j.nrl.2020.08.020] [Reference Citation Analysis]
15 Baizabal-Carvallo JF, Alonso-Juarez M. The role of viruses in the pathogenesis of Parkinson's disease. Neural Regen Res 2021;16:1200-1. [PMID: 33269775 DOI: 10.4103/1673-5374.300437] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Smeyne RJ, Noyce AJ, Byrne M, Savica R, Marras C. Infection and Risk of Parkinson's Disease. J Parkinsons Dis 2021;11:31-43. [PMID: 33361610 DOI: 10.3233/JPD-202279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Schultz EM, Jones TJ, Xu S, Dean DD, Zechmann B, Barr KL. Cerebral Organoids Derived from a Parkinson's Patient Exhibit Unique Pathogenesis from Chikungunya Virus Infection When Compared to a Non-Parkinson's Patient. Pathogens 2021;10:913. [PMID: 34358063 DOI: 10.3390/pathogens10070913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Fernández-Espejo E, Rodriguez de Fonseca F, Suárez J, Martín de Pablos Á. Cerebrospinal fluid lactoperoxidase level is enhanced in idiopathic Parkinson's disease, and correlates with levodopa equivalent daily dose. Brain Res 2021;1761:147411. [PMID: 33676939 DOI: 10.1016/j.brainres.2021.147411] [Reference Citation Analysis]